Once the infection has been resolved, MSCs shift toward anti-inflammatory phenotypes, releasing mediators such as TGF-β, indolamine 2,3-dioxygenase (IDO), IL-10, IL-1Ra, and PGE2, which control excessive immune activation and prevent cytokine storms (194, 203, 214). This evidence concerns the gene IDO1 and infection.